NEW YORK, May 18, 2020 /PRNewswire/ -- MagnaCare today
announced a collaboration with BioReference Laboratories, Inc., an
OPKO Health company (NASDAQ: OPK), to bring COVID-19 antibody
testing to their Labor clients in the New
York metropolitan area. Through this collaboration with
BioReference, MagnaCare will offer on-site antibody blood testing
to Labor members, delivering valuable information as the city,
employers and individuals plan return-to-work strategies.
"As New York's coronavirus outbreak has continued to unfold, our
Labor partners have been eager for information and guidance on
COVID-19 antibody testing — particularly since skilled trade groups
will be among the first to return-to-work and begin re-energizing
the local economy," said MagnaCare President Michelle Zettergren. "Antibody testing can
support decision making about back-to-work procedures and safety
measures for protecting workers and the public. We're proud to
bring this service to our clients so they have more knowledge, and
hopefully some peace of mind, in this challenging environment."
BioReference Laboratories, which recently worked with
New York State and New York City to provide COVID-19 antibody
testing, offers a blood test that measures SARS-CoV-2 specific
antibody levels to help determine an individual's immune response
after COVID-19 infection. Although the presence of antibodies are
typically associated with immunity, the scientific community is
still working to understand what level of antibodies might be
needed for protection from reinfection with COVID-19, and how long
that protection might last.
The collaboration will begin with on-site testing for the
District Council 9 of the International Union of Painters and
Allied Trades (IUPAT) on May 18-20.
The on-site testing is available to DC 9 members, who must go
online to pre-register and schedule their test. The cost will be
fully covered by the union, and results will be emailed directly to
members within 72 hours.
"Our goal is to get our members back to work with comfort and
confidence," said Joseph Azzopardi,
Business Manager and Secretary Treasurer of DC 9. "We're grateful
to MagnaCare for providing a convenient testing option so we can
all decide how best to move forward in the days and weeks
MagnaCare is also working with some of its other New York-based Labor partners to establish
additional on-site testing locations this month.
For more than 25
years, MagnaCare has been building healthy communities
together with Taft-Hartley funds, TPAs, carriers, and workers'
compensation and no-fault payors in the New York, New
Jersey, and Connecticut
tristate area. Its broad and wholly owned network, full health plan
management services, comprehensive in-house medical management, and
leading outcomes-based casualty solutions offer the ultimate
flexibility and customization that help customers control health
care costs, improve health, and achieve exceptional value.
MagnaCare is a division of Brighton Health Plan Solutions, LLC
About BioReference Laboratories, Inc.
provides comprehensive testing to physicians, clinics, hospitals,
employers, government units, correctional institutions and medical
groups. The company is in network with the five largest
health plans in the United States,
operates a network of 10 laboratory locations, and is backed by a
medical staff of more than 160 MD, PhD and other professional level
clinicians and scientists. With a leading position in the
areas of genetics, women's health, maternal fetal medicine,
oncology and urology, BioReference and its specialty laboratories,
GenPath and GeneDx, are advancing the course of modern
medicine. For more information, visit
Media Contact for MagnaCare:
Media Contact for BioReference
SOURCE Brighton Health Plan Solutions